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Increasing gene discovery and coverage using
RNA-seq of globin RNA reduced porcine blood
samples
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Graham S Plastow2, Christopher K Tuggle3, James M Reecy3, Eric Fritz-Waters3, Samuel M Abrams1,
Joan K Lunney1* and Le Luo Guan2*
Abstract
Background: Transcriptome analysis of porcine whole blood has several applications, which include deciphering
genetic mechanisms for host responses to viral infection and vaccination. The abundance of alpha- and beta-globin
transcripts in blood, however, impedes the ability to cost-effectively detect transcripts of low abundance. Although
protocols exist for reduction of globin transcripts from human and mouse/rat blood, preliminary work demonstrated
these are not useful for porcine blood Globin Reduction (GR). Our objectives were to develop a porcine specific GR
protocol and to evaluate the GR effects on gene discovery and sequence read coverage in RNA-sequencing (RNA-seq)
experiments.
Results: A GR protocol for porcine blood samples was developed using RNase H with antisense oligonucleotides
specifically targeting porcine hemoglobin alpha (HBA) and beta (HBB) mRNAs. Whole blood samples (n = 12) collected in
Tempus tubes were used for evaluating the efficacy and effects of GR on RNA-seq. The HBA and HBB mRNA transcripts
comprised an average of 46.1% of the mapped reads in pre-GR samples, but those reads reduced to an average of 8.9%
in post-GR samples. Differential gene expression analysis showed that the expression level of 11,046 genes were increased,
whereas 34 genes, excluding HBA and HBB, showed decreased expression after GR (FDR <0.05). An additional 815 genes
were detected only in post-GR samples.
Conclusions: Our porcine specific GR primers and protocol minimize the number of reads of globin transcripts in whole
blood samples and provides increased coverage as well as accuracy and reproducibility of transcriptome analysis.
Increased detection of low abundance mRNAs will ensure that studies relying on transcriptome analyses do not miss
information that may be vital to the success of the study.
Keywords: Pig, Blood, Globin reduction, RNA-seq, Transcriptome
Background
Blood is a valuable resource to probe an animal’s
physiological and pathological status as well as to obtain
repeated samples before harvest, for example, monitoring
the dynamic change of gene expression in response to
disease, treatment, or aging, for which the onset of gene
expression response is not known. However, transcriptomic
analysis of blood samples is a challenge since blood is
composed of heterogeneous cell types including red
blood cells (99%), platelets (1%) and white blood cells
(<1%; e.g., neutrophils, monocytes, basophils, lymphocytes
and eosinophils) [1,2]. In human blood, HBA and HBB are
the most abundant transcripts (~52-76%) [3,4]. The high
level of globin transcripts in blood was reported to be the
most limiting factor for accurate and sensitive detection of
gene expression, especially for the less abundant
transcripts [3-5]. This issue is a great concern for
sequence-based approaches, in which the globin transcripts
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will be highly abundant and limit the potential coverage
and detection of other transcripts from blood [3].
To date, several globin RNA reduction protocols have
been successfully applied to gene expression studies in
human [6-9]. GLOBINclearTM (Ambion, Austin, TX, USA),
a commercial product widely used in human clinical
research, removes up to 95% of the HBA and HBB
transcripts in human whole blood samples and improves
the efficacy of gene expression assays [4,10,11]. Further
approaches developed by Affymetrix (Affymetrix Inc.,
Santa Clara, CA, USA) [5,11] or PNA Bio Inc. (Thousand
Oaks, CA, USA) [9,10] also have differential reduction
rates of globin transcripts in human blood. Globin RNA
reduction improved the sensitivity and reproducibility of
high throughput mRNA expression analysis of whole
human blood samples [3-5,7,9,10]. There is, however,
neither a commercial GR product available nor any
literature demonstrating the efficiency and effects of
GR at global level for porcine whole blood [2].
Our objectives were to develop a porcine specific GR
protocol and to evaluate the effects of GR treatment on
gene discovery and coverage in RNA-seq experiments
for swine.
Results and discussion
Comparisons of globin reduction methods
To determine the suitability of the GR process for
porcine whole blood samples, we initially evaluated
the efficacies of three distinct methods (GLOBINclearTM,
biotinylated PNA and RNase H) with whole blood samples
drawn from 12 pigs collected in either PAXgeneTM (n = 3)
or TempusTM (n = 9) tubes. To evaluate and compare GR
efficiency, we performed qPCR analysis of HBA and HBB
transcripts with a pooled sample for GLOBINclear and
PNA methods and 5 randomly selected samples for the
RNase H method (Additional file 1: Table S1). The
GLOBINclearTM-Human Kit (Ambion, Austin, TX, USA),
commonly used in human samples, seemed to have merit
as it employs a non-enzymatic magnetic method but
its reduction efficiency in pig barely reached 64%
and 67% for HBA and HBB transcripts, respectively
(Additional file 1: Figure S1). The manufacturer confirmed
that porcine HBA and HBB sequences had low sequence
homology to their corresponding human oligonucleotide
probes used in the GLOBINclearTM-Human Kit, but the
degree of dissimilarity is not known because the human
probe sequences used in the GLOBINclearTM Kit are not
publicly available. Next, we designed porcine specific
biotinylated PNA oligonucleotides and used them with
the GLOBINclearTM Kit. This PNA oligo method,
however, reduced levels of HBA and HBB transcripts only
40% and 34%, respectively (Additional file 1: Figure S1).
Third, we evaluated the RNase H mediated GR method
using porcine specific oligonucleotides modified from the
Affymetrix GeneChip GR Protocol developed for re-
duction of human globin transcripts [5]. We examined
the sequence similarities of HBA and HBB, especially the
oligonucleotide sequences on 3′ UTR, between human
and pig using Clustal Omega (Additional file 1: Figure S2)
[12]. Due to a lack of consensus, we designed two sets of
porcine specific oligonucleotides each for HBA and HBB
(Table 1). This revised RNase H mediated GR protocol
resulted in an average reduction of 94% of HBA and 92%
of HBB transcripts from porcine whole blood samples
(Additional file 1: Figure S1). Thus we determined that the
RNase H GR method using our custom designed porcine
specific oligos was the most efficient of the three GR
methods tested here and confirmed its efficacy by
RNA-seq (Additional file 1: Table S2).
Performance of GR protocol in an RNA-Seq experiment
After determining the valid and highly efficient GR method,
we evaluated the effects of the RNase H GR treatment on
gene discovery and coverage in an RNA-seq experiment.
Since the above study on the GR method included samples
collected using different blood collection tubes and RNA
isolation methods, we evaluated the effects of the RNase H
GR treatment on gene discovery and coverage in an
RNA-seq experiment with a different set of 12 porcine
blood samples collected in TempusTM tubes and for
which the RNA was isolated by a magnetic bead based
MagMaxTM kit.
More than 653 million (M) sequence reads generated
from 12 pre- and post-GR samples passed Illumina’s
CASAVA (v.1.8) filtration (Table 2). These reads were
then aligned to the pig genome build 10.2 by TopHat
(v. 2.0.8). After GR treatment, total filtered reads and
mapped reads were reduced by an average of 6.1 M
and 6.8 M reads, respectively, and globin reads were
reduced by an average of 11.4 M reads. The percentage of
globin reads among all aligned reads averaged 46.1% and
of these, 84.7% were removed by GR treatment. The
proportion of globin reads to mapped reads were 46.1%
and 8.9% in pre- and post-GR samples, respectively, and
proportions of HBA and HBB reads to mapped reads were
significantly reduced to 5.2% from 26.1% and to 3.7% from
20.1%, respectively (p <0.001, Figure 1). Considering that
human globin transcripts constitute 50-70% of the blood
Table 1 Porcine specific globin oligonucleotides used in
RNase H-mediated globin reduction assay
Gene Sequence Final Conc.
(10X)
HBA 5′- GAT CTC CGA GGC TCC AGC TTA ACG GT -3′ 7.5 uM
5′- TCA ACG ATC AGG AGG TCA GGG TGC AA -3′ 7.5 uM
HBB 5′- AGG GGA ACT TAG TGG TAC TTG TGG GC -3′ 30 uM
5′- GGT TCA GAG GAA AAA GGG CTC CTC CT -3′ 30 uM
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RNA [3,4], the level of pig globin transcripts in pre-GR
samples is comparatively low. A possible explanation for
the lower level of porcine globin transcripts is that the
pigs used in this study were only 1-2 months old, an age
associated with rapid decreases in erythrocyte population
size and hemoglobin concentration. Although pigs at birth
have similar hematological values to adult pigs, by three
days of age a 25% reduction in hemoglobin concen-
tration has occurred and hemoglobin concentration then
increased gradually from the age of 3 months due to the
pig’s tremendous early growth rate, as much as eight times
faster than humans [13,14]. Thus, we expect the GR
protocol will reduce more globin transcripts in newborn
and adult pig blood RNAs.
Table 2 RNA-seq mapping statistics for pre- and post-globin reduction samples
pre-Globin Reduction post-Globin Reduction
Sample RINa Total
readsb
Aligned
readsb
Expressed
genesc
HBA
readsb
HBB
readsb
RINa Total
readsb
Aligned
readsb
Expressed
genesc
HBA
readsb
HBB
readsb
1 7.8 23.66 22.45 11269 7.57 4.19 8.0 18.00 16.45 12175 2.35 1.60
2 7.7 19.73 18.57 11591 5.43 3.40 7.8 21.62 19.56 12736 2.16 1.29
3 7.6 26.12 24.62 11445 8.24 4.96 7.7 21.68 19.91 12246 3.69 2.17
4 7.9 23.78 22.29 11796 6.68 3.80 7.5 25.57 22.94 12942 1.93 1.28
5 7.5 23.67 22.38 10966 7.23 4.63 7.4 19.81 17.59 12409 0.29 0.26
6 6.8 24.58 22.79 10671 6.30 3.82 7.0 17.79 15.60 11613 0.26 0.17
7 6.8 23.53 21.42 11517 2.82 2.76 6.4 21.03 18.50 11736 0.34 0.20
8 6.5 22.01 20.18 11900 4.54 2.13 5.9 18.40 16.20 12203 0.08 0.06
9 5.0 45.16 41.89 11464 9.36 12.64 4.9 25.33 21.86 11834 0.28 0.55
10 4.7 39.39 36.09 11319 8.46 8.37 4.5 34.33 29.36 12214 0.17 0.27
11 4.2 46.71 42.13 11292 8.92 9.74 4.1 34.64 29.45 11680 0.31 0.74
12 3.7 44.94 41.68 10441 9.96 12.16 3.5 31.81 27.31 11322 0.30 0.48
aRIN: RNA Integrity Number provided by Agilent 2100 bioanalyzer.
bPaired read counts are given in millions.
cGenes are considered expressed when read count >5.
A total of 24 samples were loaded onto different lanes according to RIN measured after globin reduction (sample 1–6: high RIN, sample 7–8: moderate RIN and
sample 9–12: low RIN).
Figure 1 The average proportions of HBA and HBB reads to total mapped reads in pre- and post-GR samples. Solid and pattern bars
show the average (± s.d.) proportions of globin reads in pre- and post-GR samples, respectively. RNase H mediated GR protocol decreased both
proportions of HBA and HBB reads to mapped reads significantly (Paired Wilcoxon signed rank test, p <0.001).
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Classification of samples based on RNA integrity
number (RIN)
We examined the RIN changes after GR treatment of
pig blood RNA and its effect on sequencing results. The
quality of RNA was not changed overall (p >0.1); though
8 samples showed a reduction in RIN after GR treatment,
only 3 samples showed a marked decrease of RIN (0.4-0.6)
after GR. However, there was a reduction in RNA yield
following GR treatment with only 33.3-78.2% of total
RNA being recovered. Studies on GR treatment in humans
also reported the reduction of RNA yields ranging from
52-95% of total RNA [3,4,7,15]. The reasons for the
significant reduction and the wide variation in RNA yield
are not clear. To offset the RNA loss accompanying GR
treatment, it would be desirable to prepare sufficient
amounts of initial RNA. Because we identified possible
bias introduced by RIN from the preliminary sequencing
results (data not shown), we empirically classified the
samples into three categories based on RIN after GR
treatment: high (RIN ≥7), moderate (5 ≤ RIN <7), and
low (RIN <5) representing ideal, critical and inferior
RNA integrity for RNA-seq experiments, respectively.
Increased coverage of non-globin genes in post-GR
samples
Following an approach similar to that described by
Mastrokolias et al. [3], we investigated the effect of
GR on enhancing the coverage of non-globin genes
and the sensitivity of gene expression detection. Read
count data was normalized by library size and DE
genes between pre- and post-GR samples were determined
using edgeR (see Methods). Compared to pre-GR samples,
11,046 genes showed higher level of detection (expression)
and 34 genes (Table 3), excluding HBA and HBB and
ENSSSCG00000014727 (hemoglobin subunit beta-like),
showed lower level of detection after GR treatment
(FDR <0.05) (Figure 2a). We checked for sequence
similarities among these 34 genes and the four globin oligo-
nucleotides for possible non-target specific hybridization,
but found none.
Figure 2b depicts a heatmap of the normalized log2
transformed expression of the 11,046 genes with higher
level of detection in post-GR samples compared to pre-GR
samples. It was observed that a large set of genes in the
low RIN samples (within the boxes in Figure 2b) was
considerably lower expressed than the corresponding set in
the high/moderate RIN samples, both pre- and post-GR.
We believe that these are the genes with the greatest
degradation in the low RIN samples. We then examined
the variation in gene body coverage from 5′ to 3′ in high/
moderate and low RIN samples, respectively. Low RIN
samples showed strong bias toward increased coverage at
the 3′ end (Figure 3). Among the low-quality RNA
samples, pre- and post-GR treatment showed the same
trend of bias, which affirmed that the RNase H treatment
was not the determining factor. High quality samples
showed better coverage from 5′ to 3′ as well as at the
ends in both pre- and post-GR treated samples. All low
quality samples were biased toward increased coverage at
the 3′ end, possibly due to the degradation of RNA.
However, the number of unique genes detected did not
differ significantly between low and high RIN samples.
The lower detection levels of a small number of genes
in post-GR samples could also be due to the effect of
RIN. We investigated all genes with decreased level of
detection after GR (fold change <0) from each sample
independently, regardless of statistical significance
(Additional file 1: Figure S3). We observed that samples
with the most notable RIN change after GR (RIN
reduction ≥0.4) had the highest number of genes
with decreased expression level (samples 4, 7 and 8;
Additional file 1: Figure S3). In addition to the effect of
RIN, technical variations or sampling effects could also
contribute to differences in detection levels of genes.
Increased number of non-globin genes identified in
post-GR samples
The number of detected genes (read counts >5) in post-GR
samples was significantly increased compared to pre-GR
samples (paired t-test) (Figure 4a). GR treatment increased
the gene detection rate by 8.6% in high RIN samples, 2.2%
in moderate and 5.4% in low RIN samples. It was also
noticed that the number of additional genes identified in
post-GR samples was higher for samples with a high RIN
(Figure 4b). It may be noted that the detection rate was
higher in high RIN samples compared to low RIN samples
despite being sequenced at half the depth. Pre-GR, an
average of 93 genes were uniquely detected in the high
RIN group, whereas 243 genes were uniquely detected in
the moderate/low RIN group. Post-GR, the corresponding
uniquely detected genes in the two groups were 1,157 and
753, respectively (Additional file 1: Figure S4).
We next determined genes expressed in porcine whole
blood using all 12 samples, based on the criterion that a
gene was detected at read counts above 5 in at least 5 of
the 12 samples. We identified 12,588 genes in post-GR
samples and 11,826 genes in pre-GR samples with an
overlap of 11,773 genes (Figure 5). Excluding the overlap,
815 genes were detected only in post-GR samples,
whereas 53 were specific to pre-GR samples. The small
number of genes found specific to pre-GR samples may
be due to the effect of RIN or technical variations. A
comparison of the mean expressions of the set of 11,773
genes detected in both pre- and post-GR samples and the
815 genes detected only in post-GR samples revealed
increased expression in post-GR samples (Additional file 1:
Figure S5). The mean expression of the 815 additional
genes in post-GR samples was well below the lower
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quartile of the expression levels of genes common to
both pre- and post-GR samples. Thus GR treatment
increases the ability to detect genes expressed at very low
levels.
Conclusions
The porcine specific GR protocol described here success-
fully removed a significant proportion of the HBA and
HBB transcripts prior to sequence analysis. The range of
gene discovery from RNA sequencing was extended with
significant increases in number of identified genes via
improved coverage. Our DE analyses using the GR sam-
ples showed increased sensitivity, with no observed strong
negative effects as a result of the GR protocol. We also
demonstrated the effects of RIN on blood RNA-seq
analyses. Thus, the GR protocol incorporated into porcine
blood transcriptomics will help advance pig physiological,
pathological and blood biomarker studies, by providing
Table 3 The list of 34 genes that showed decreased expression level after globin reduction
Ensembl ID Genea Gene descriptiona
ENSSSCG00000028278 POLR2A polymerase (RNA) II (DNA directed) polypeptide A, 220 kDa
ENSSSCG00000022476 – –
ENSSSCG00000012570 – –
ENSSSCG00000024020 RERE arginine-glutamic acid dipeptide (RE) repeats
ENSSSCG00000028814 SOD3 superoxide dismutase 3, extracellular
ENSSSCG00000031032 SLA-DRB3b MHC class II, DR beta-like 3 pseudogene
ENSSSCG00000006328 RXRG Retinoic acid receptor RXR-gamma
ENSSSCG00000003562 SFN stratifin
ENSSSCG00000004389 – –
ENSSSCG00000000386 ANKRD52 ankyrin repeat domain 52
ENSSSCG00000011331 – –
ENSSSCG00000010913 – –
ENSSSCG00000022894 GZMH granzyme H
ENSSSCG00000027961 – –
ENSSSCG00000011258 EXOG endo/exonuclease (5′-3′), endonuclease G-like
ENSSSCG00000022933 EFR3B EFR3 homolog B (S. cerevisiae) [Source: HGNC Symbol; Acc:29155]
ENSSSCG00000029574 – –
ENSSSCG00000010915 – –
ENSSSCG00000022681 – –
ENSSSCG00000000253 KRT18 keratin 18
ENSSSCG00000029399 – –
ENSSSCG00000013264 PHF21A PHD finger protein 21A
ENSSSCG00000009603 – –
ENSSSCG00000009444 OLFM4 olfactomedin 4
ENSSSCG00000030191 – –
ENSSSCG00000029430 – –
ENSSSCG00000023324 KMT2A lysine (K)-specific methyltransferase 2A
ENSSSCG00000015124 PVRL1 poliovirus receptor-related 1 (herpesvirus entry mediator C)
ENSSSCG00000025712 – –
ENSSSCG00000013547 CRB3 crumbs homolog 3 (Drosophila)
ENSSSCG00000026303 PROSER1 proline and serine rich 1
ENSSSCG00000003942 – –
ENSSSCG00000013545 TUBB4A tubulin, beta 4A class IVa
ENSSSCG00000001513 SYNGAP1 synaptic Ras GTPase activating protein 1
aOrthologous human gene symbol provided where available. Unannotated genes was presented as “–”.
bpseudogene.
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more targets for drug development and disease resistance
research.
Methods
Blood samples and RNA isolation
Animal protocols were approved by the Kansas State
University and University of Alberta Animal Care and
Use Committees. A total of 24 blood samples were used
to conduct two independent studies: comparisons of
three GR methods to select the best method and
evaluating the effects of the selected GR method on
an RNA-seq experiment. For the first study, 3 mL of blood
samples from 9 pigs of 1-2 months age produced from
Landrace x Large White selected from a commercial
populations used in the Porcine reproductive and
respiratory syndrome Host Genetics Consortium (PHGC)
studies [16] were collected in TempusTM Blood RNA
tubes (Life Technologies, Carlsbad, CA, USA) and 2.5 mL
of blood samples from 3 crossbred pigs of Large
White x Landrace were collected in PAXgeneTM
Blood RNA tubes (PreAnalytiX, Qiagen, Germany) at
the University of Alberta. Total RNA was isolated
with PAXgeneTM Blood RNA Kit (PreAnalytiX, Qiagen)
for PAXgeneTM tubes and either TempusTM Spin RNA
Isolation Kit (Life Technologies, Carlsbad, CA, USA)
or magnetic bead based MagMaxTM for Stabilized
Blood Tubes RNA Isolation Kit for Tempus tubes
(Life Technologies), according to the respective manufac-
turer’s instructions.
For the second study evaluating the effects of
RNase H mediated GR protocol on RNA-seq, another
set of 12 blood samples were drawn from crossbred
pigs of Duroc x (Landrace x Yorkshire) in a PHGC
population. Three mL of blood from each pig at 1-2
months of age was collected into TempusTM Blood
RNA Tubes at Kansas State University. Total RNA was iso-
lated using the MagMaxTM for Stabilized Blood Tubes
RNA isolation kit according to the manufacturer’s protocol.
RNA concentration was quantified using a NanoDrop
ND-1000 spectrophotometer (Nano-Drop Technologies,
Wilmington, DE, USA) and RNA quality was assessed
using an Agilent Bioanalyzer 2100 (Agilent Technologies,
Inc., Santa Clara, CA, USA). To determine an accurate
28S/18S rRNA ratio in the pig, we aligned the human
28S sequence against pig genome build 10.2 using
BLAST and identified 97-100% of similarity on pig
chromosome 6: 871128-866484 (Ensembl release 73).
The sizes of the 28S and 18S genes in pig were estimated
to be 4645 bp and 2302 bp, respectively, yielding an
rRNA ratio of 2.02, whereas the rRNA ratios in
human and mouse are known to be 2.69 and 2.53,
respectively (the ratio obtained from Genbank database;
M11167 and X03205 in human and NR003279 and
NR003278 in mouse).
Figure 2 Differential gene expression in pre- versus post-GR samples. a. MA plot revealed that the majority of the differentially expressed
genes showed increased detection (11,046) in post-GR samples and only 34 (excluding globin genes) showed lower detection. b. Heatmap shows
the expression profile across all samples for the 11,046 genes with increased detection by GR treatment. A large set of genes in the low RIN samples
(within the orange boxes) was considerably lower expressed than the corresponding set in the high/moderate RIN samples.
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Design of porcine specific oligonucleotides
We first tested GLOBINclearTM Human Kit (Ambion,
Austin, TX, USA) which hybridized biotinylated oligonu-
cleotides with globin transcripts by binding to Streptavidin
Magnetic Beads. Second, we designed porcine specific
biotinylated Peptide Nucleic Acids (PNA) oligos to
inhibit reverse transcription of globin transcripts (HBA:
5′-CGAGGCTCCAGCTTA-3′ and HBB: 5′-CACCAGC
CACCACCT-3′). Third, we designed four porcine specific
antisense oligonucleotides for HBA and HBB using Primer
Figure 3 Normalized 5′ to 3′ sequence coverage by position showing lower expression in one representative low RIN sample. For lower
expressed 4,792 genes in low RIN samples, the average read numbers of low RIN (<5) and moderate/high RIN (≥5) in pre- and post-GR samples is
shown at each relative position.
Figure 4 Increased gene coverage as a result of globin reduction. GR treatment increased the detection of expressed genes (read >5). 6 high
(RIN ≥7) and 2 moderate (5≤ RIN <7) RIN samples were sequenced in one lane and 4 low (RIN <5) RIN samples were sequenced in another lane.
a) Comparisons of number of expressed genes in pre- and post-GR treatment. b) RIN influence on identifying additional genes post-GR treatment.
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3 (v. 0.4.0) (Table 1) to hybridize with globin tran-
scripts prior to digestion with RNase H. To design
porcine specific oligonucleotides, we first used Clustal
Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/) to
align the porcine HBA (ENSSSCT00000008741) and HBB
(ENSSSCT00000016076) transcript sequences in the current
assembly of the pig genome (build 10.2) with their
orthologues from human, mouse, cow and pig obtained
from the Ensembl database (http://www.ensembl.org) and
then checked the similarity of the 3′ end hybridization
sites (Additional file 1: Figure S2).
Globin reduction treatment
GR treatment with porcine specific oligonucleotides was
performed using a modified Affymetrix GR protocol [5].
In brief, 10X GR oligonucleotides mix was prepared adding
100 uL each of two HBA Oligos at 30 uM, two HBB Oligos
at 120 uM per reaction, yielding a final concentration of
7.5 uM HBA Oligos and 30 uM HBB Oligos. Three ug of
denatured total RNA was hybridized in a thermal cycler at
70°C for 2 min with the 400 uL 10X GR oligonucleotides
mix in hybridization buffer (100 mM Tris-HCL, pH 7.6;
200 mM KCl) at 70°C for 5 min, then cooled to 4°C. The
RNA-DNA hybrids were digested with 2 U RNase H
(Ambion) in the reaction buffer (100 mM Tris–HCl,
pH 7.6, 20 mM MgCl2, 0.1 mM DTT, SUPERase-In)
at 37°C for 10 min and cooled to 4°C. The reaction
was stopped by addition of 1.0 ul 0.5 M EDTA.
RNase H treated RNA was immediately purified with
the RNeasy MinElute Cleanup Kit (Qiagen, Toronto,
Canada, Cat. No.: 74204) according to manufacturer’s
instructions. RNA quality of GR treated samples was
assessed using an Agilent Bioanalyzer 2100 (Agilent
Technologies, Inc.).
Quantitative real-time PCR (qPCR) analysis
We quantified the mRNA level of the porcine HBA and
HBB transcripts by SYBR Green I based qPCR using a
StepOneTM Real-Time PCR System (Applied Biosystems,
Foster City, CA, USA). First strand cDNA was synthesized
using SuperScript® II reverse transcriptase (Invitrogen)
and random hexamer primers in a final volume of 20 μL
following the manufacturer’s instruction. SYBR Green I
based qPCR was performed in a total volume of 10 μL
per reaction comprising 2 μL of template, 1 μL of the
assay-specific primer mix, 5 μL of the Fast SYBR® Green
Master Mix Bulk Pack (Applied Biosystems) and 2 μL of
water. The reaction conditions used were one cycle of
95°C for 3 min for initial denaturation, 23 cycles of
95°C for 30 s and 60°C for 30 s. The primer sequences are
shown in Additional file 1: Table S1.
Library preparation for sequencing
Poly-A + fractions from the GR treated samples and
respective non GR treated samples (1.5 μg RNA each) were
purified by using oligo-dT magnetic beads (Illumina, Inc.,
San Diego, USA), and used to construct cDNA libraries.
The Poly (A+) RNA was primed with random hexamers
and fragmented at 94°C for 8 min. Second strand cDNA
was synthesized after the first strand cDNA using
SuperScript II (Invitrogen). The cDNA fragments were
end-repaired and a single ‘A’ nucleotide was added to
3′-ends to prevent them from cross ligation during the
adapter ligation step. Then individual RNA adapter index
oligos were ligated to the end-repaired cDNA and
subsequently amplified using Veriti Thermo cycler
(Applied Biosystems). The initial denaturation was
performed at 98°C for 30 seconds, followed by 15 cycles at
98°C for 10 seconds, annealing at 60°C for 30 seconds and
extension at 72°C for 30 seconds. The final extension was
followed at 72°C for 5 minutes, and held at 10°C.
The quality and size (~260 bp) of the resulting cDNA
libraries were assessed using the High sensitivity DNA Kit
(Agilent Technologies, Inc.) in an Agilent Bioanalyzer 2100
(Agilent Technologies, Inc.). The quantification was
performed using StepOneTM Real-Time PCR System
(Applied Biosystems), as suggested in the Sequencing
Library qRT-PCR Quantification Guide (Illumina, Inc.).
The KAPA SYBR® FAST ABI Prism qPCR Kit (Kapa
Biosystems, Inc., Woburn, USA) was used for the qPCR
reactions. The individual libraries were pooled into 2 nM
after quantification.
Sequencing was performed on the HiSeq System
(Illumina, Inc.). The pooled 10 μL of the 2 nM libraries were
diluted and denatured. The pooled cDNA libraries (12 pM)
were loaded on the cBot (Illumina, Inc.) for clustering on a
flow cell, and single-read cluster generation proceeded using
the TruSeqTM SR Cluster Generation Kit v3 (Illumina,
Inc., Cat.: FC-930-3001). A portion of each library was
diluted to 10 nM and stored at -20°C. Fifty cycles of
sequencing-by-synthesis using the paired-end protocol
was performed on a HiSeq (Illumina, Inc.) according to
manufacturer’s instructions. Real-time analysis and base
Figure 5 Venn diagram of number of genes identified as
expressed in pre- versus post-GR samples. There is significant
overlap (11,773) between pre- and post-GR samples. An additional
815 genes were identified in only post-GR samples.
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calling was performed using the HiSeq Control Software
Version 1.4.8 (Illumina, Inc.).
Bioinformatic analysis
Sequence reads with base quality scores were produced
by the Illumina sequencer. Raw reads were processed using
the Illumina CASAVA (v. 1.8) to filter out the low-quality
reads. Sequence reads were then aligned to the pig genome
reference assembly (build 10.2; [17]) using TopHat 2.0.8
[18] with default parameters. The number of reads
uniquely mapped to each gene (Ensembl 71 annotation)
was determined using Htseq-count (v0.5.3.p3; [19]). To
determine number of genes identified in each sample, we
required a read count >5.
To identify genes detected at decreased or increased
levels between the globin reduced and non-reduced
samples, the read count data were analysed using edgeR
(version 3.0.8) [20] in R (version 2.15.2), as described [3].
Count data was normalized by the library size to account
for different numbers of reads obtained from each sample.
To determine differences in detection levels between the
two groups, an exact test for the negative binomial
distribution was used. The genes were considered to be
differentially detected at FDR <0.05. RSeQC (v2.3.3) [21]
was used for read distribution over gene body to
check 5′/3′ bias. We used BlastN (v2.2.25) [22] to perform
the alignment between globin oligos and the genes with
decreased levels after GR treatment.
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gene expression comparing three different globin reduction methods.
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